NEW SUMMER SERIES – Spotlight on practicalities of prescribing SGLT2 inhibitors in Type 2 Diabetes management
Prescribing Information will be available at the meeting.
The programme will be aimed at Primary Care HCPs – GPs, pharmacists and nurses who oversee type 2 diabetic patients. There is a big unmet need in terms of translating current evidence and guidance into front line clinical practice.
The overarching objective is to improve the knowledge and confidence of primary care health practitioners in the management of type 2 diabetic patients by offering practical, case-based guidance from our panel of experts. In addition you will be introduced to two simple and effective tools to help during consultations.
The webinars
Wednesday 31st July, 19:00-20:00 hours
Webinar 1: The evolving role of SGLT2is in Type 2 Diabetes management
- Recap on how SGLT2i’s work, evolving evidence base, positioning in guidelines as the new ‘standard of care’
- Prescribing hesitancy – Exploring the gap between guideline recommendations and SGLT2i use
- Identifying individuals likely to benefit most from SGLT2-inhibitor treatment
- Presenting the Improving Diabetes Steering Committee (IDSC) SGLT2i Decision Tool
Wednesday 21st August, 19:00-20:00 hours
Webinar 2: Evidence-informed practical guidance for safe and appropriate prescribing of SGLT2is in type 2 diabetes
- Interactive case-based discussions using the IDSC Decision Tool
- Recognising important contraindications and cautions
- Introducing and using the SGLT2i initiation checklist to support safe and effective prescribing
- Conveying the benefits and risks during the consultation
The expert panel
Jane Diggle
Specialist Diabetes Nurse Practitioner, West Yorkshire
Nicola Milne
Primary Care Diabetes Specialist, Manchester
Dr Pam Brown
GP, SA1 Medical Practice
You must be an Issues & Answers member* to register for this programme, login below:
*If you are not already a member click here to register for FREE.
This educational programme has been supported by:
A. Menarini Farmaceutica Internazionale SRL (Menarini) have provided funding support towards this independent programme. This is a promotional meeting for GB-registered healthcare professionals only. Menarini products may be discussed during the meeting.
Menarini have had no input into the agenda, choice of speaker or content of the meeting but have certified the slides for compliance with the pharmaceutical industry code of practice.
The content, opinions and statements made in this programme are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board.
PP-IN-UK-1735 / May 2024
